Tradestie Institutional Equity Comparison Engine
NVS vs UNOV โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NVS Overall Edge
NVS Captures Institutional Edge (4โ0 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Novartis AG (NVS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NVS trades at 16.1x Forward P/E with 34.0% operating margin (+4.7% YoY revenue) versus UNOV at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, NVS sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro) against UNOV sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
NVS
NVS 16.1x vs UNOV N/M Fwd P/E
Growth & Margin Winner
NVS
Op Margin 34.0% vs N/A ยท YoY +4.7% vs N/A
Momentum & Technical Winner
NVS
1Y +21.4% vs +9.5% ยท 52W Pos 78% vs 84%
Options & Structure Winner
NVS
UNCLASSIFIED (6th %ile IV) vs UNCLASSIFIED (N/A IV)
NVS
NYSE
Novartis AG
Pharmaceutical Preparations
$160.20
-0.19% 1D
Market Cap
$303.1B
1M Return
+6.36%
1Y Return
+21.45%
Forward P/E
16.1x
Unified AI Score
43.7 / 100
HOLD
Tech 37.0
Fund 37.0
Flow 50.0
Mom 21.1
UNOV
Cboe BZX
Innovator U.S. Equity Ultra Buffer ETF - November
Pharmaceutical Preparations
$41.13
-0.95% 1D
Market Cap
N/A
1M Return
-0.97%
1Y Return
+9.53%
Forward P/E
N/M
Unified AI Score
58.7 / 100
HOLD
Tech 48.0
Fund 60.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NVS +21.45%
UNOV +9.53%
Spread: +11.92 pp (NVS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NVS TTM Op. Margin: 34.0%
UNOV TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NVS vs UNOV. Trailing 12-month operating profitability (NVS 34.0% vs UNOV N/A) and valuation multiples (NVS 16.1x vs UNOV N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NVS | UNOV | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $303.1B | N/A | Larger Scale | NVS |
| Trailing P/E Ratio Valuation | 30.6x | N/M | Lower Multiple | NVS |
| Forward P/E Ratio Valuation | 16.1x | N/M | Lower Multiple | NVS |
| Revenue Growth (YoY) Growth | +4.7% | N/A | Higher Growth | NVS |
| Operating Margin (TTM) Profitability | 34.0% | N/A | Higher Margin | NVS |
| Net Profit Margin Profitability | 17.5% | N/A | Higher Margin | NVS |
| Return on Equity (ROE) Capital Efficiency | 24.3% | N/A | Higher ROE | NVS |
| 52-Week Range Position Momentum | 78% ($123โ$170) | 84% ($37โ$42) | Stronger Trend | UNOV |
| Beta / 30D Volatility Risk Regime | 0.31ฮฒ ยท 27% Vol | 0.46ฮฒ ยท 11% Vol | Lower Realized Risk | UNOV |
| Unified Institutional Score Composite Signal | 43.7 / 100 (HOLD) | 58.7 / 100 (HOLD) | Higher Composite | UNOV |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NVS vs UNOV Buy Guide
NVS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
UNOV
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NVS nor UNOV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.